報價延遲最少15分鐘:2025/06/03 18:08 EDT
|
|
|
|
|
||||||||||||
|
|
|
|
|
38.878 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-2.64/3.55
|
|
企業價值
5.04B
|
| 資產負債 |
|
每股賬面淨值
11.63
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
301.03M
|
|
每股收益
11.24
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/06/03 18:08 EDT
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development. |